BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)

Q: What does CUSIP 07725L102 represent in this 13F holders report?

CUSIP 07725L102 is the security identifier for ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in Q4 2017?

93 institutional investors reported ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share for Q4 2017. Use the holders table for investor-level position and value details.

CUSIP: 07725L102

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding: 1,448,978,913
Total 13F shares: 27,567,001
Share change: +2,369,994
Total reported value: $2,693,889,000
Put/Call ratio: 198%
Price per share: $97.72
Number of holders: 93
Value change: +$229,200,708
Number of buys: 54
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 07725L102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	0.31%	4,489,948	$464,529,000	—	30 Sep 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	0.27%	3,898,431	$403,332,000	—	30 Sep 2017	13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	13F	Company	0.27%	3,896,782	$403,161,000	—	30 Sep 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.19%	2,778,783	$287,493,000	—	30 Sep 2017	13F
ORBIMED ADVISORS LLC	13F	Company	0.09%	1,313,788	$135,925,000	—	30 Sep 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.07%	967,760	$100,124,000	—	30 Sep 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.05%	776,840	$80,372,000	—	30 Sep 2017	13F
Boxer Capital, LLC	13F	Company	0.04%	600,000	$62,076,000	—	30 Sep 2017	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.04%	600,000	$62,076,000	—	30 Sep 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	499,556	$51,684,000	—	30 Sep 2017	13F
Temasek Holdings (Private) Ltd	13F	Company	0.03%	380,000	$39,315,000	—	30 Sep 2017	13F
Prince Street Capital Management LLC	13F	Company	0.02%	345,800	$35,777,000	—	30 Sep 2017	13F
BlackRock Finance, Inc.	13F	Company	0.02%	344,345	$35,626,000	—	30 Sep 2017	13F
BROWN ADVISORY INC	13F	Company	0.02%	333,699	$34,525,000	—	30 Sep 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.02%	326,159	$33,744,000	—	30 Sep 2017	13F
INDUS CAPITAL PARTNERS, LLC	13F	Company	0.02%	316,835	$32,780,000	—	30 Sep 2017	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.02%	292,005	$30,211,000	—	30 Sep 2017	13F
Rock Springs Capital Management LP	13F	Company	0.02%	280,000	$28,969,000	—	30 Sep 2017	13F
CREDIT SUISSE AG/	13F	Company	0.02%	251,839	$26,055,000	—	30 Sep 2017	13F
Myriad Asset Management Ltd.	13F	Company	0.02%	238,185	$24,643,000	—	30 Sep 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	235,549	$24,368,000	—	30 Sep 2017	13F
Artal Group S.A.	13F	Company	0.02%	225,000	$23,279,000	—	30 Sep 2017	13F
MORGAN STANLEY	13F	Company	0.01%	199,597	$20,651,000	—	30 Sep 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	184,417	$19,080,000	—	30 Sep 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	150,309	$15,551,000	—	30 Sep 2017	13F
VANGUARD GROUP INC	13F	Company	0.01%	110,882	$11,472,000	—	30 Sep 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	94,933	$9,822,000	—	30 Sep 2017	13F
BAILLIE GIFFORD & CO	13F	Company	0.01%	80,010	$8,278,000	—	30 Sep 2017	13F
Polar Capital LLP	13F	Company	0.01%	75,000	$7,760,000	—	30 Sep 2017	13F
DAFNA Capital Management LLC	13F	Company	0%	71,849	$7,433,000	—	30 Sep 2017	13F
CITIGROUP INC	13F	Company	0%	67,637	$6,998,000	—	30 Sep 2017	13F
FIRST TRUST ADVISORS LP	13F	Company	0%	57,142	$5,912,000	—	30 Sep 2017	13F
CONNING INC.	13F	Company	0%	53,451	$5,530,000	—	30 Sep 2017	13F
Fosun International Ltd	13F	Company	0%	53,451	$5,530,000	—	30 Sep 2017	13F
Ariose Capital Management Ltd	13F	Company	0%	52,600	$5,442,000	—	30 Sep 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0%	47,482	$4,912,000	—	30 Sep 2017	13F
State of New Jersey Common Pension Fund D	13F	Company	0%	46,010	$4,760,000	—	30 Sep 2017	13F
UBS Group AG	13F	Company	0%	45,696	$4,727,000	—	30 Sep 2017	13F
NORGES BANK	13F	Company	0%	43,233	$4,473,000	—	30 Sep 2017	13F
ALPS ADVISORS INC	13F	Company	0%	41,739	$4,318,000	—	30 Sep 2017	13F
University Of Notre Dame du Lac	13F	Individual	0%	35,603	$3,683,000	—	30 Sep 2017	13F
Vident Investment Advisory, LLC	13F	Company	0%	29,191	$3,020,000	—	30 Sep 2017	13F
STATE STREET CORP	13F	Company	0%	25,774	$2,667,000	—	30 Sep 2017	13F
TD ASSET MANAGEMENT INC	13F	Company	0%	23,568	$2,437,000	—	30 Sep 2017	13F
EMORY UNIVERSITY	13F	Company	0%	23,061	$2,386,000	—	30 Sep 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0%	20,039	$2,073,000	—	30 Sep 2017	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0%	18,700	$1,935,000	—	30 Sep 2017	13F
Belpointe Asset Management LLC	13F	Company	0%	15,868	$1,642,000	—	30 Sep 2017	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	15,586	$1,613,000	—	30 Sep 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0%	14,684	$1,519,000	—	30 Sep 2017	13F

Institutional Holders of BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) as of Q4 2017

As of 31 Dec 2017, BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,567,001 shares. The largest 10 holders included FMR LLC, Hillhouse Capital Management, Ltd., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, OppenheimerFunds, Inc., CANADA PENSION PLAN INVESTMENT BOARD, and Boxer Capital, LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders

Q4 2017 holders

Holder diff

Investor	Q3 2017 Shares	Q4 2017 Shares	Share Diff	Share Chg %	Q3 2017 Value $	Q4 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.